A was associated with lower rates of perioperative
stroke and superior overall survival.93
Less has been reported on the inï¬‚uence of statins on
CAS outcomes, but available data parallel those for
CEA. In a retrospective review of 53 patients who underwent CAS in a single institution, the 30-day stroke/death/
MI rate was 4% in patients on statins and 15% among
those not on statins at the time of